About Jubilant Generics
Jubilant Generics is a Healthcare company based in Noida (India). It focuses on RD and manufacturing of drugs for various therapeutic areas. It operates on a B2B model. The company has 1,106 employees. Its Indian entity Jubilant Generics Limited reported revenue of ₹327 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and R&D Services.
Company details
Jubilant Generics focuses on rd and manufacturing of drugs for various therapeutic areas through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and providing RD services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
- Headquarters Noida, India
- Employees 1,106
- SectorsHealthcare
- Website jubilantgenerics.com
- Social LinkedIn Facebook Instagram
- Legal Name Jubilant Generics Limited
- Date of Incorporation 25 Nov, 2013
- Jurisdiction Noida, Uttar Pradesh, India
- Annual Revenue₹327 Cr
FY 2023 · -75% YoY
- Net Loss-₹189 Cr
FY 2023 · -58% margin
- EBITDA-₹103 Cr
FY 2023 · -32% margin
- Employee Count1,106
Associated legal entities of Jubilant Generics
Jubilant Generics operates through Jubilant Generics Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Jubilant Generics Limited CIN U24100UP2013FLC060821 | Active | 25 Nov 2013 | Noida, Uttar Pradesh | ₹327 Cr | 1,106 | 5 | View details |
Board of directors of Jubilant Generics Limited (Jubilant Generics)
Jubilant Generics Limited is the primary company behind Jubilant Generics. The board of Jubilant Generics Limited currently have 3 directors; the longest-serving is Jaidev Sanjeev Rajpal, appointed in 2022. 24 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jaidev Sanjeev Rajpal DIN 09734618 | Managing Director | 11 Oct 2022 | 4 yrs | Jubilant Generics Limited |
| Gayatri Taragi DIN 09245540 | Director | 21 May 2024 | 2 yrs 4 mo | Jubilant Generics Limited |
| Shirish Gundopant Belapure DIN 02219458 | Director | 20 Jun 2024 | 2 yrs 3 mo | Jubilant Generics Limited |
People of Jubilant Generics
12 people are tracked at Jubilant Generics (7 in leadership, 5 in team); the tracked headcount is 1,106.
| Name | Role | Group |
|---|---|---|
Prashant Chauhan | Sr. Director - Human Resources | Leadership |
Dr. Jaidev Rajpal | MD & CEO | Leadership |
Varun Jha | Head Of Quality Assurance | Leadership |
Trupti Borgaonkar | Europe Head- Sales & Business Development | Leadership |
Robin Shahi | Associate Director - Human Resources | Leadership |
Shikha Aggarwal | Chief Financial Officer | Leadership |
Cyrus Patel | Senior Director Finance | Leadership |
Sumit Baliyan | Quality Assurance | Team |
Arpit Kumar | Quality Assurance Officer | Team |
Amit Kumar Sahu | Sr. Manager -pv QA (corporare Quality Assurance) | Team |
Pratibha Sharma | Senior Human Resources Manager | Team |
Akash Shrivastava | Manager | Team |
Complete people profiles for Jubilant Generics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Jubilant Generics
Figures of Jubilant Generics Limited, the primary company behind Jubilant Generics, for FY 2023. Revenue was ₹327 Cr (-75% year on year). Net loss was -₹189 Cr (-58% margin). EBITDA was -₹103 Cr (-32% margin). Revenue has grown at a compounded annual rate of -35% over three years and -20% over five years.
- ₹327 CrRevenue · FY 2023 · -75% YoY
- -₹189 CrNet loss · -58% margin
- -₹103 CrEBITDA · -32% margin
- ₹2.58 CrPaid-up capital
- 1,106Employees (provident fund records)
- -35%Revenue CAGR, 3 years
- -20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Jubilant Generics Limited are on its company page.
Detailed financial statements for Jubilant Generics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Jubilant Generics
The website of Jubilant Generics (jubilantgenerics.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 9.6% vs previous month
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Jubilant Generics (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jubilant Generics
Complete news archive for Jubilant Generics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jubilant Generics
Jubilant Generics is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
Jubilant Generics has 1,106 employees.
The primary company behind Jubilant Generics, Jubilant Generics Limited, reported revenue of ₹327 Cr for FY 2023, down 75% year on year.
Jubilant Generics focuses on rd and manufacturing of drugs for various therapeutic areas through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and providing RD services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Jubilant Generics operates through Jubilant Generics Limited.
The legal entities of Jubilant Generics currently have 4 directors, including Gayatri Taragi, Jaidev Sanjeev Rajpal, Shirish Gundopant Belapure and others.